Francisco-José López-Jaime

5PUBLICATIONS
23CO-AUTHORS
GenomicsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2026
Resolving structural variants in hemophilia: insights from long-read sequencing and molecular and clinical implications.

|Jan 07, 2026
Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.

Johnny Mahlangu, Ana Boban, Maria Bruzelius

|Aug 12, 2025
Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19.

Ana Marco-Rico, Adrián Montaño, Francisco López-Jaime

|Jun 16, 2023
Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX-FP): A case report.

Francisco José López-Jaime, Ihosvany Fernández-Bello, Eva Calavia-Aranda

|Jan 13, 2023
Expert opinion paper on the treatment of hemophilia a with emicizumab.

Francisco-José López-Jaime, Olga Benítez, Bolívar Luis Díaz Jordán

Pageof 1

Frequent Collaborators

3 joint publications

Adrián Montaño

2 joint publications

Ihosvany Fernández-Bello

2 joint publications

María Del Carmen Gómez-Del Castillo Solano

1 joint publications

Johnny Mahlangu